INB-200: FULLY ENROLLED PHASE 1 STUDY of GENE-MODIFIED AUTOLOGOUS GAMMA-DELTA (γ?) T CELLS in NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) PATIENTS RECEIVING MAINTENANCE TEMOZOLOMIDE (TMZ)

Authors
Category Primary study
Conference29th Congress of the European Hematology Association, EHA 2024
Year 2024
This article has no abstract
Epistemonikos ID: 79c23f549d6dc1cd245ca51ae835f9bef1262ac2
First added on: Mar 07, 2026